RT Journal Article
SR Electronic
T1 Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
JF British Heart Journal
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 486
OP 487
DO 10.1136/hrt.73.5.486
VO 73
IS 5
A1 A. Politi
A1 M. Sticca
A1 M. Galli
YR 1995
UL http://heart.bmj.com/content/73/5/486.abstract
AB Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).